Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
Brief Summary: To allow patients with HIV-associated wasting to receive thalidomide treatment at 1 of 2 doses. To gain safety and efficacy data from a broader base of patients with HIV-associated wasting in order to support Celgene's pivotal placebo-controlled study.